memantine   Click here for help

GtoPdb Ligand ID: 4253

Synonyms: Axura® | Ebixa® | Namenda®
Approved drug
memantine is an approved drug (EMA (2002), FDA (2003))
Compound class: Synthetic organic
Comment: Memantine is a non-competitive NMDA receptor antagonist approved for Alzheimer's disease but is also being studied in non-dementia psychiatric disorders [1] .
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: memantine

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 1
Hydrogen bond donors 1
Rotatable bonds 0
Topological polar surface area 26.02
Molecular weight 179.17
XLogP 3.52
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC12CC3CC(C1)(C)CC(C2)(C3)N
Isomeric SMILES CC12CC3CC(C1)(C)CC(C2)(C3)N
InChI InChI=1S/C12H21N/c1-10-3-9-4-11(2,6-10)8-12(13,5-9)7-10/h9H,3-8,13H2,1-2H3
InChI Key BUGYDGFZZOZRHP-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Memantine reduces clinical worsening in moderate to severe AD [2].
Memantine is a component of the approved AD fixed-dose medication Namzaric® (which contains memantine plus donepezil).
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Memantine blocks NMDA glutamate channels. For a complete overview of the mechanism of action of memantine, please see the DrugBank link on the Summary tab of this ligand page..
External links Click here for help